4.6 Article

Neutrophil extracellular traps and inflammasomes cooperatively promote venous thrombosis in mice

Journal

BLOOD ADVANCES
Volume 5, Issue 9, Pages 2319-2324

Publisher

ELSEVIER
DOI: 10.1182/bloodadvances.2020003377

Keywords

-

Categories

Funding

  1. British Heart Foundation [PG/18/46/33817]
  2. British Heart Foundation Senior Basic Science Research Fellowship [FS/19/30/34173]
  3. Henry Wellcome Fellowship [218649/Z/19/Z]
  4. Wellcome Trust [218649/Z/19/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

The study shows a potential interaction between neutrophil extracellular traps (NETs) and inflammasomes in the development of DVT, which may support the formation of venous thrombosis through this mechanism.
Deep vein thrombosis (DVT) is linked to local inflammation. A role for both neutrophil extracellular traps (NETs) and the assembly of inflammasomes (leading to caspase1-dependent interleukin-1 beta activation) in the development of DVT was recently suggested. However, no link between these 2 processes in the setting of thrombosis has been investigated. Here, we demonstrate that stimulation of neutrophils induced simultaneous formation of NETs and active caspase-1. Caspase-1 was largely associated with NETs, suggesting that secreted active caspase-1 requires NETs as an adhesive surface. NETs and their components, histones, promoted robust caspase-1 activation in platelets with the strongest effect exerted by histones 3/4. Murine DVT thrombi contained active caspase-1, which peaked at 6 hours when compared with 48-hour thrombi. Platelets constituted more than one-half of cells containing active caspase-1 in dissociated thrombi. Using intravital microscopy, we identified colocalized NETs and caspase-1 as well as platelet recruitment at the site of thrombosis. Pharmacological inhibition of caspase-1 strongly reduced DVT in mice, and thrombi that still formed contained no citrullinated histone 3, a marker of NETs. Taken together, these data demonstrate a cross-talk between NETs and inflammasomes both in vitro and in the DVT setting. This may be an important mechanism supporting thrombosis in veins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Low-dose Btk inhibitors selectively block platelet activation by CLEC-2

Phillip L. R. Nicolson, Sophie H. Nock, Joshua Hinds, Lourdes Garcia-Quintanilla, Christopher W. Smith, Joana Campos, Alexander Brill, Jeremy A. Pike, Abdullah O. Khan, Natalie S. Poulter, Deidre M. Kavanagh, Stephani Watson, Callum N. Watson, Hayley Clifford, Aarnoud P. Huissoon, Alice Y. Pollitt, Johannes A. Eble, Guy Pratt, Steve P. Watson, Craig E. Hughes

Summary: In this study, it was demonstrated that Btk inhibitors selectively block the activation of human platelets through CLEC-2 as opposed to GPVI, suggesting a potential therapeutic use at low doses in patients with thrombo-inflammatory diseases.

HAEMATOLOGICA (2021)

Editorial Material Hematology

Integrin α9β1: a new target to fight thrombosis

Alexander Brill

BLOOD (2020)

Article Cell Biology

An adaptable analysis workflow for characterization of platelet spreading and morphology

Jeremy A. Pike, Victoria A. Simms, Christopher W. Smith, Neil V. Morgan, Abdullah O. Khan, Natalie S. Poulter, Iain B. Styles, Steven G. Thomas

Summary: The assessment of platelet spreading and quantification through light microscopy is crucial for platelet biologists. The presented workflow uses image segmentation and machine learning to analyze a large number of cells efficiently. The method is freely available and implemented using open-source software.

PLATELETS (2021)

Review Biochemistry & Molecular Biology

Pulmonary Artery Thrombosis: A Diagnosis That Strives for Its Independence

Olga Porembskaya, Yana Toropova, Vladimir Tomson, Kirill Lobastov, Leonid Laberko, Viacheslav Kravchuk, Sergey Saiganov, Alexander Brill

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Hematology

Novel gene variants in patients with platelet-based bleeding using combined exome sequencing and RNAseq murine expression data

Abdullah O. Khan, Rachel J. Stapley, Jeremy A. Pike, Susanne N. Wijesinghe, Jasmeet S. Reyat, Ibrahim Almazni, Kellie R. Machlus, Neil Morgan

Summary: The UK Genotyping and Phenotyping of Platelets study aimed to identify candidate gene mutations in 74 patients with platelet-based bleeding for future research. By using data frame indexing and a gene panel, novel and rare variants were identified, and patients were indexed against a murine RNA sequencing dataset to reveal candidate gene variants.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Editorial Material Hematology

von Willebrand Factor A Loyal Ally of Venous Thrombosis in Obesity

Joana Campos, Alexander Brill

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Article Hematology

Heterozygous mutation SLFN14 K208N in mice mediates species-specific differences in platelet and erythroid lineage commitment

Rachel J. Stapley, Christopher W. Smith, Elizabeth J. Haining, Andrea Bacon, Sian Lax, Vera P. Pisareva, Andrey Pisarev, Steve P. Watson, Abdullah O. Khan, Neil Morgan

Summary: SLFN14 has been identified as an endoribonuclease that regulates protein synthesis by cleaving RNA, impacting lineage commitment in hematopoiesis. A knock-in mouse model with a SLFN14 mutation similar to that found in human patients showed distinct phenotypes, with platelet defects in humans and severe microcytic erythrocytosis in mice, highlighting the species-specific role of SLFN14 in mammalian hematopoiesis.

BLOOD ADVANCES (2021)

Editorial Material Biochemistry & Molecular Biology

Multiple Facets of Venous Thrombosis

Alexander Brill

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Hematology

Rare missense variants in Tropomyosin-4 (TPM4) are associated with platelet dysfunction, cytoskeletal defects, and excessive bleeding

Rachel J. Stapley, Natalie S. Poulter, Abdullah O. Khan, Christopher W. Smith, Patricia Bignell, Carl Fratter, Will Lester, Gillian Lowe, Neil Morgan

Summary: The study identified rare conserved missense variants in TPM4 gene in 3 patients, leading to platelet function defects. The research highlights the importance of including TPM4 in diagnostic genetic screening for patients with significant bleeding and undiagnosed platelet disorders.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Cardiac & Cardiovascular Systems

Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature

Abdullah O. Khan, Jasmeet S. Reyat, Harriet Hill, Joshua H. Bourne, Martina Colicchia, Maddy L. Newby, Joel D. Allen, Max Crispin, Esther Youd, Paul G. Murray, Graham Taylor, Zania Stamataki, Alex G. Richter, Adam F. Cunningham, Matthew Pugh, Julie Rayes

Summary: This study found that the interaction between pericytes and endothelial cells is disrupted in COVID-19 infection, leading to increased microvascular endothelial permeability, which may result in thrombotic and bleeding complications.

CARDIOVASCULAR RESEARCH (2022)

Article Oncology

Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies

Abdullah O. Khan, Antonio Rodriguez-Romera, Jasmeet S. Reyat, Aude-Anais Olijnik, Michela Colombo, Guanlin Wang, Wei Xiong Wen, Nikolaos Sousos, Lauren C. Murphy, Beata Grygielska, Gina Perrella, Christopher B. Mahony, Rebecca E. Ling, Natalina E. Elliott, Christina Simoglou Karali, Andrew P. Stone, Samuel Kemble, Emily A. Cutler, Adele K. Fielding, Adam P. Croft, David Bassett, Gowsihan Poologasundarampillai, Anindita Roy, Sarah Gooding, Julie Rayes, Kellie R. Machlus, Bethan Psaila

Summary: This study presents a human bone marrow organoid that can support the growth and survival of primary cells from patients with myeloid and lymphoid blood cancers. This organoid model allows for mechanistic studies of blood cancers within their microenvironment and serves as an ex vivo tool for prioritizing new therapeutics.

CANCER DISCOVERY (2023)

Article Immunology

The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function

Christopher Mapperley, Louie N. van de Lagemaat, Hannah Lawson, Andrea Tavosanis, Jasmin Paris, Joana Campos, David Wotherspoon, Jozef Durko, Annika Sarapuu, Junho Choe, Ivayla Ivanova, Daniela S. Krause, Alex von Kriegsheim, Christian Much, Marcos Morgan, Richard I. Gregory, Adam J. Mead, Donal O'Carroll, Kamil R. Kranc

Summary: The study reveals that YTHDF2 acts as a repressor of inflammatory pathways in hematopoietic stem cells, and long-term deletion of YTHDF2 results in HSC dysfunction and ultimately leads to multilineage hematopoiesis failure.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

No Data Available